CIDRAP newsletters options
Faster antimicrobial treatment did not lead to increased antibiotic use.
COVID-19 cases jumped 18% last week and are at their highest levels since April, the WHO says.
Symptoms of long COVID are more frequently reported by women, those with poor overall health before the pandemic, and those aged 50 to 60, according to a new UK-based study in Nature Communications.
The study was based on results gathered from 6,907 people with self-reported COVID-19 from 10 population-based longitudinal health surveys in the United Kingdom that had been in place prior to the pandemic.
A new report from the World Organisation for Animal Health (WOAH, formerly OIE) shows global use of antimicrobials in animals fell by 27% from 2016 through 2018.
Also, "Many individuals are presenting with atypical symptoms," the WHO says.
VRBPAC experts approved the booster recommendation by a 17-to-2 vote.
A new study from researchers at Boston University (BU) shows that, for all but 17% of healthy, vaccinated young adults, the infectious period for COVID-19 from the Delta and Omicron variants was 5 days. The study was recently published in Clinical Infectious Diseases.
As cases top 4,000 worldwide, WHO consultants take a wait-and-see approach.
The incidence dropped by one-fifth for both mRNA vaccines when dose spacing was longer.
The WHO says it has received reports of 920 probable cases from 33 countries.
Emergent BioSolutions said in a news release late last week that the US Food and Drug Administration (FDA) has accepted for review an adjuvanted version of its anthrax vaccine for post-exposure prophylaxis (prevention) of anthrax.
The Journal of Infectious Diseases has published studies demonstrating lower COVID-19 incidence—but a higher risk of severe disease—in people with Down syndrome (DS), and a lower COVID vaccine immune response.
An additional 600,000 lives might have been saved if global vaccination goals had been met.
The number of genetic substitutions is 6 times higher than expected for an orthopoxvirus.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A study of adults discharged from more than 900 US hospitals in 2019 found that more than one-third received empiric gram-negative antibiotic therapy, with more than 1 in 5 receiving broad-spectrum antibiotics, researchers reported yesterday in Clinical Infectious Diseases.
A study yesterday in JAMA Internal Medicine shows that a fourth Pfizer COVID-19 vaccine dose provided 64% to 67% protection against hospitalization and 72% protection against death in nursing home residents, but only 34% protection against infection during an Omicron-dominated period.
The absolute risk appears to be only slightly higher than in uninfected peers.
Also, global experts meet to consider if the threat constitutes a global public health emergency.
Typhoid fever has become increasingly resistant to antibiotics over the past 50 years.
